reviewNature Reviews Drug DiscoveryApr 30, 2010Closed access

Alzheimer's disease: strategies for disease modification

MCMartin Citron

Eli Lilly (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,063
total citations
FWCI
49.28
Percentile
100%
References
117
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Disease
  • Medicine
  • Neurology
  • Clinical trial
  • Intensive care medicine
  • Alzheimer's disease
  • Amyloid beta
  • Amyloid (mycology)
No related works found for this paper.

Funding